parkinson’s disease and coffee: is high consumption a protective factor or aversion to coffee taste a risk factor?
Objective: To evaluate the association between coffee consumption and preference for the taste of coffee with Parkinson's Disease (PD). Background: Previous studies point to a…A randomized, phase 2a, double-blind, placebo-controlled clinical trial with NE3107 adjunctive to carbidopa/levodopa in patients with Parkinson’s disease
Objective: To evaluate the motor effects of NE3107 treatment in patients with levodopa-treated Parkinson’s disease (PD) experiencing motor fluctuations. Background: NE3107 is an oral, blood-brain…Depression and Activities of Daily Living in Idiopathic Parkinson’s Disease without Dementia.
Objective: Objective: To study the influence of depression on ADLs in patients with PD in stages I and II of Hoenh and Yahr. Background: Background:…Modulatory effect of posture on prepulse inhibition in Parkinson’s disease and atypical Parkinsonism
Objective: Here, we describe how sPPI from the leg is modulated in different balance conditions in patients with Parkinson’s disease (PD) and progressive supranuclear palsy…Caveats regarding a family with PD and LRRK2 mutations
Objective: To describe and discuss genetic considerations regarding a kindred with PD cases with similar clinical characteristics, some with identified mutations in the LRRK2 gene…Words Spoken Daily: A Novel Measure of Cognition
Objective: To assess the average number of words spoken per day by individuals with Parkinson’s disease (PD), mild cognitive impairment (MCI), and control participants. Background:…Impact of vitamin supplements intake on non-motor fluctuations measured by (NoMoFA) in people living with Parkinson’s disease.
Objective: To determine the impact of vitamins supplements on non-motor fluctuations in people living with Parkinson's disease (PEP). Background: Parkinson's disease (PD) is a neurodegenerative…Foslevodopa/foscarbidopa in patients with advanced Parkinson’s disease: subgroup analyses from a phase 3, randomized study
Objective: Present the efficacy and safety of 24-hour/day continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) across pre-specified subgroups (age, sex, body mass index [BMI], race,…Developement and acceptability testing of a patient decision aid on levodopa/carbidopa intestinal gel.
Objective: To develop a patient decision aid on levodopa/carbidopa intestinal gel (LCIG) and to test its acceptability. Background: : Advanced Parkinson’s disease (PD) is characterized…Rest Tremor in Parkinson’s Disease Is Associated with Increased Ipsilateral DAT Binding
Objective: To investigate the connection between striatal dopamine transporter binding and cardinal motor symptoms of Parkinson’s disease. Background: The three cardinal motor symptoms of Parkinson’s…
- « Previous Page
- 1
- …
- 323
- 324
- 325
- 326
- 327
- …
- 553
- Next Page »